ILKN421Hpembrolizumabadvanced solid tumors1L NSCLC
…ed so far. In Part A, 9 patients in three dose cohorts received ILKN421H. All patients demonstrated high and prolonged plasma level of I…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 338 of 2459Advanced pancreatic canceriNeo-Vac-R01Zhejiang University School of Medicinepancreatic cancerSir Run Run Shaw Hospitaladvanced digestive system cancerfirst-line chemotherapystandard first-line chemotherapy
…Background Advanced pancreatic cancer remains a highly lethal malignancy with limited treatment optio…
ischaemic heart diseasetype 2 diabetesstrokeCardiometabolic multimorbiditychronic pain
… least two cardiometabolic diseases, involving type 2 diabetes, ischaemic heart disease and stroke.Results After a median follow-up of 13.7 years, 4445…
hepatitis BPeg-IFNHBVPeg-interferon
… were included. At the start of peg-IFN therapy (SOT), 44% were hepatitis B envelope antigen (HBeAg) positive, mean HBsAg level was 3.03 lo…
epinephrineNCT02722746ropivacaine
…+2 µg/mL epinephrine, and 16 received 0.2% ropivacaine +5 µg/mL epinephrine. The overall rate of hypotension was 21.3% (10/47). There were …
melanomamelanoma-specificipilimumabnivolumabtertiary care center
…ssociated with MSS, OS, PRFS or DMFS in patients with stage III melanoma treated with ICIs, although irAE grade was associated with MSS.…
Cetirizinediphenhydramineimmuno-oncology treatmentschemotherapy
…to mitigate allergic reactions by blocking histamine receptors. Cetirizine, a second-generation antihistamine, may offer advantages over t…
95.6%
University of MarylandUniversity of Maryland Medical CenterAIC Kijabe Hospitalsolid tumorshematological malignanciesNational Commission for Science and TechnologyAKUHNChimeric antigen receptor (CAR) T-cell therapyAga Khan University HospitalMinistry of Health+1 more
…er types.Ethics Approval Study participants were recruited from University of Maryland [NCI-Maryland BRCA studies (1993-2003 and 2012-2016), Aga Khan …
99.0%
Dana-Farber Cancer InstituteDartmouth Cancer CenterRhode Island HospitalICIHNSCCR/M HNSCC
…ents with R/M HNSCC receiving ICI (n = 114) were recruited from Dana-Farber Cancer Institute, Dartmouth Cancer Center, and Rhode Island Hospital. Whole bloo…
Butyratenon-small cell lung cancerMelanomaICB
…s the responsiveness of CD8+ T-cells with exhausted phenotypes. Butyrate demonstrated an ability to alter the expression of immune check…
endometrial carcinomanon-small cell lung cancercervical canceradvanced renal cell carcinomahepatocellular carcinomaCTX-10726Compass Therapeutics
…r, advanced renal cell carcinoma, hepatocellular carcinoma, and endometrial carcinoma. The simultaneous targeting of VEGF-A and PD-1 in a single mole…